Back

Statin use and cardiovascular outcomes after myocardial infarction: a population-based case-control study

26 August 2022 (16:15 - 16:55)
Organised by:
Congress Presentation Part of: Statin therapy: clinical role and current challenges Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Ville Kyto

Turku University Hospital, Turku (Finland)

5 More presentations in this session

Presentation thumbnail
Impact of high-intensity statin therapy on glycemic control post-acute coronary syndrome using real-world data
Doctor M. Abdelghani (Doha, QA)
Abstract Slides
Presentation thumbnail
The association between long-term statin use and cataract in both primary and secondary prevention of cardiovascular disease - a nationwide, cohort study on 597,605 cataract patients
Doctor A. Halili (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Perioperative rosuvastatin therapy increases creatine kinase and the risk of acute kidney injury in patients undergoing cardiac surgery
Doctor R. Wijesurendra (Oxford, GB)
Abstract Slides
Presentation thumbnail
Use of statins in cancer patients following acute myocardial infarction and its impact on long-term clinical outcomes.
Doctor K. Stepien (Krakow, PL)
Abstract Slides
Presentation thumbnail
Drucebo effect in statin therapy: more attributable to the patient, the doctor, or the mass media?
Doctor D. Cosmi (Perugia, IT)
Abstract Slides

Access the full session

Session thumbnail
Statin therapy: clinical role and current challenges

The Event

Event poster

ESC Congress 2022

26 August 2022 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Statins for secondary prevention of coronary artery disease in patients aged 80 years or older: a nation-wide propensity score-based analysis
26 April 2024
thumbnail
Congress Presentation
Improving smoking cessation after myocardial infarction by systematically implementing evidence-based treatment methods: a prospective observational cohort study
27 August 2021
thumbnail
Webinar
Reducing risk in the post-MI patient
6 September 2023
thumbnail
Congress Presentation
Intravenous administration of IV-STATIN CARDIOSHIELD during myocardial infarction renders higher cardioprotection than oral atorvastatin given shortly after reperfusion: a translational CMR study
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources